G6PD and neoplasm: Using serial sections of the xenografted tumor, we performed in situ hybridization and immunohistochemistry staining, and confirmed a decrease in p52-ZER6 and G6PD expression in xenografted tumors formed by p52-ZER6-silenced HCT116p53null cells (Fig. 6G).